My group is dedicated to understanding how the interactions between infectious organisms and the human immune system result in pathogenesis and/or durable immunity. Our work is primarily focused on viral pathogens, and leverages "next generation" technologies such as single cell RNA sequencing, multi-parametric flow cytometry, and computational modeling.